Check out these names.
Previously studies already showed improvement from use of Exelixis's Cabometyx over Pfizer's Sutent in treating kidney cancer patients.
Stocks turn mixed on Tuesday, though the Nasdaq remains on track to set to record a close for its third day in a row.
Stocks turn higher Tuesday as crude oil declines and the fourth-quarter earnings season draws closer.
Stock futures are little changed on Tuesday as investors await news from a press conference Wednesday with President-elect Donald Trump. Oil prices level off.